With the rollout of several coronavirus vaccines all over the world, India’s drug regulator, Central Drugs Standard Control Organisations (CDSCO), too, has approved two vaccines — Covishield and Covaxin. 

Both Covishield (AstraZeneca vaccine manufactured by Serum Institute of India) and Covaxin (manufactured by Bharat Biotech Limited) have been approved for emergency restricted use in India. 

Taking the availability of vaccines into consideration, the Indian government has divided the vaccine distribution into various categories, with some of the first doses going to selected priority groups who are at higher risk of contracting the deadly virus. 

In the first phase of the vaccination drive, all healthcare workers, along with other frontline and municipal workers, including the state and central police department, armed forces, home guard, disaster management, civil defence organisations, and prison staff, were administered the vaccine, as per the recommendation by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC). 

Read more at: https://yourstory.com/socialstory/2021/04/covid19-vaccine-india-covishield-covaxin-vaccination-details